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Abstract
Background Colorectal endoscopic submucosal dissection
(ESD) was developed in Japan and is growing in popularity
in Europe. Patients undergoing a colorectal ESD procedure
in Japan are hospitalized for several days. In this study, we
investigated the feasibility of colorectal ESD as an outpa-
tient procedure in a European setting.
Methods A prospective cohort of all patients undergoing
colorectal ESD at Danderyds Hospital, Stockholm, Sweden
from April 2014 to December 2015 were studied. Data on
patient demographics, procedural outcome and 30-day
readmissions were studied. Data are presented as median
(range), mean ± SD or true numbers as appropriate.
Results A total of 182 patients underwent a colorectal ESD
during the study period. Of the 182 these, 11 were sched-
uled for an in-hospital procedure and of 171 patients
scheduled for a day-procedure and 15 were admitted for
observation. The remaining 156 patients were discharged
after 2–4 h of observation and comprise the study cohort.
Mean age was 69 years. Median lesion size was 28
(10–120) mm, and median resection time was 65 (10–360)
min. Lesions were located as follows: anal canal 1 (0.6%),
rectum 52 (33.3%), sigmoid 17 (10.9%), descending 3
(1.9%), transverse 24 (15.4%), ascending 29 (18.6%), and
cecum 30 (19.2%). Eight (5.1%) of the 156 day surgery
patients returned for medical attention during the postop-
erative 30-day period. Three of them were admitted for in-
hospital observation. None of the day surgery patients
required any surgical intervention.
Conclusion Uncomplicated colorectal ESD can safely be
carried out in a day surgery setting.
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Endoscopy
Colorectal cancer is the third most common cause of can-
cer-related death in Sweden [1]. The pathogenesis is
described by the adenoma–carcinoma sequence where
neoplastic polyps are precursors to invasive submucosal
cancer in colon and rectum [2]. In many European coun-
tries, including Sweden, colorectal cancer screening pro-
grams have been implemented. These screening programs
lead to increased detection rates of precancerous adenomas
as well as superficial carcinomas. Removal of these lesions
lowers the incidence of colorectal cancer [3–5].
Endoscopic removal of stalked polyps can be easily
managed with snare polypectomy. Smaller sessile and flat
adenomas can be removed en bloc with endoscopic
mucosal resection (EMR). Larger adenomas ([20 mm in
diameter) are difficult to remove en bloc with EMR [6, 7].
The options for removal of these lesions are endoscopic
piecemeal mucosal resection (EPMR) or endoscopic sub-
mucosal dissection (ESD). EPMR is considered as a time-
efficient method with a short learning curve and with low
complication rates. The drawbacks of EPMR are that it is
difficult for the pathologist to assess the depth of the lesion
and to ensure microscopic radical removal. High recur-
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and Other Interventional Techniques 
In contrast, ESD enables en bloc resection of lesions
regardless of size with low recurrence rates [10]. In addition,
the pathologist receives a specimen where all important
features such as invasion depth, lymphovascular invasion,
grade of differentiation and tumor budding can be assessed
and thereby give the clinician solid information to base
further treatment strategies on. However, ESD is considered
technically challenging, with a long learning curve and it can
be time-consuming. It has a higher risk of complications such
as perforation and bleeding compared to EPMR [11]. To
date, there is no clinical evidence concerning the need for
hospitalization and when to begin food ingestion after a
routine colorectal ESD. In Japan, with the largest experience
of colorectal ESD, a routine ESD procedure is followed by
nill per mouth on postoperative day one and a hospital stay of
at least 2–4 days [12, 13]. Small European series also report
inpatient care for two to three days with an initial fasting
period after an ESD procedure [14].
This strategy could be questioned since new postoper-
ative protocols for colorectal surgery stress the importance
of early food intake and mobilization. In addition, unnec-
essary hospitalization leads to increased health care costs.
Therefore, we investigated the feasibility of colorectal ESD
as an outpatient procedure in a consecutive series of col-
orectal ESDs.
Materials and methods
Based on the indications proposed by the Colorectal ESD
Standardization Implementation Working Group and
Colorectal ESD/EMR Guidelines established by the Japan
Gastroenterological Endoscopy Society [15], all patients
admitted to the Endoscopic Unit at Danderyds Hospital,
Stockholm, Sweden with an early colorectal neoplasm
larger than 20 mm, a local recurrence after earlier endo-
scopic treatments or where the position of the lesions or the
endoscopic surface pattern did not make it suitable for
EMR treatment, underwent colorectal ESD. Tumors
showing endoscopic signs of deep submucosal invasion
were referred for surgical resection.
Colonic cleansing was performed at home using
2000–3000 ml of polyethylene glycol (PEG) solution on the
day before the treatment and 1000–2000 ml of PEG the day
of the procedure. The patients came to the endoscopic unit
fully prepped. No prophylactic antibiotics were adminis-
tered. The ESD procedure was performed with a transparent
cap (D201-11804,12704; 4 mm Olympus) fitted endoscope
(GIF-H180 J, GIF-1TH190, PCF-190AI, Olympus, Tokyo
Japan). Needle knives specially designed for ESD with
minor modifications to the diathermy tip (Dual knife, KD-
650Q, Olympus, Tokyo Japan) were used for the ESD
procedure with a high-frequency generator (ERBE,
Elektromed-VIO300D, Tubingen, Germany). When bleed-
ing or vascular structures were encountered, hemostasis
with a coagulation forceps (Coagrasper FD411-QR,
Olympus, Tokyo Japan or SB junior, Sumitomo, Tokyo
Japan) were used. Conscious sedation using midazolam and
alfentanil was started with 2 and 0.5 mg doses intra-
venously, respectively and if required. Additional doses
were administrated during the procedure on the endo-
scopists assessment. Hyoscine butyl bromide 10 mg was
administered intravenously during the procedure if needed.
After the ESD procedure, patients were observed for
2–4 h and discharged if no significant symptoms such as
increased abdominal pain or discomfort were seen. During
this time-period, they were allowed to eat. Patients were
admitted for in-hospital observation if their clinical status
deteriorated after the procedure or if a procedural com-
plication was anticipated.
Resected specimens were pinned with needles on a
specimen plate, and the lesion and specimen size were
measured. Subsequently, the specimens were immersed in
10% formalin and sectioned serially in 2 mm intervals for
histological evaluation. Vienna classification was used to
classify the colorectal specimens. En bloc resection was
defined as resection in one piece of tissue for the whole
lesion. Microscopically R0 resection was defined as no
tumor cells in lateral or vertical resection margin whereas
R1 resection was defined as lateral and/or vertical resection
margin with tumor cells. Microscopically RX resection was
used when the resection margin could not be fully assessed
due to diathermy effects on the tissue.
Complications and follow-up
Complications were defined as immediate or delayed.
Perforations during the procedure were defined as com-
plete, when serosa or intraperitoneal tissues was visualized,
or partial, when fibers in the muscularis propria were
incised, but no complete perforation occurred.
Statistics and ethics
Data are presented as median (range), mean ± SD or true
numbers as appropriate. Patient charts were assessed for
any readmission within 30 days. The study protocol fol-
lows the Helsinki Declaration and was approved by the
hospital institutional review board.
Results
During the study period, April 7, 2014 to December 31,
2015, a total of 182 colorectal ESDs were performed on
171 persons. Eleven patients were scheduled for an
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inpatient procedure. The reasons were living more than
100 km from hospital (3 patients), distal lesion requiring
general anesthesia for adequate pain relief (3 patients) and
age or co-morbidities that disabled patient to manage
bowel preparation at home (5 patients). Patients on anti-
platelet and/or anti-coagulant drugs were included in the
study with a treatment criteria of PT-INR\ 1.8. Anti-
platelet drugs were discontinued 3–5 days before the pro-
cedure. Fifteen cases were initially planned as day surgery
but were admitted to the hospital after the procedure at
discretion of treating physician. Of these 15, one had an
intraprocedural bleeding during rectal ESD that was not
possible to manage endoscopically. He underwent emer-
gent transanal endoscopic microsurgery (TEM) procedure.
Postoperative course was uneventful. Eight had a trans-
mural perforation of the bowel wall treated with clips and
antibiotics. One of these eight patients required a laparo-
scopic wedge resection of the cecum postoperative day one
after a cecal ESD procedure due to local peritonitis and
free abdominal air. The postoperative course was
uneventful. When comparing the 15 patients admitted to
hospital after their colorectal ESD with the study cohort the
former had a longer procedure time (median 170 (10–300)
minutes), larger lesion size (median 45 (20–81) mm) and
lesions were localized in cecum and ascending colon to a
higher extent (73 vs 38%). Median length of stay was 1
[1–3] day. The remaining 156 cases out of a total of 182
were done in day surgery and these make up the study
cohort (Fig. 1).
The sex distribution was 75 (48%) men and 81 (52%)
women. Mean age was 69.4 ± 11.0 years. Distribution of
the lesions is presented in Table 1. Endoscopic tumor
characteristics are presented in Table 2. Of the flat lesions,
a total of 83 were classified as lateral spreading tumor
(LST) granular and 26 as LST non-granular. The most
common indication for ESD in the cohort was a lesion size
[20 mm (141 patients (90.3%)). Other indications were
rectal carcinoid (one patient), lesions reaching the dental
line (two patients), lesion extending into the ileocecal valve
(one patient), LST non-granular lesions (three patients) and
where position of the lesion made en bloc EMR hard to
perform (eight patients).
Of the 156 cases, 152 (97.4%) were completed with
ESD technique. Two (1.3%) cases were finished with
snaring after mucosal incision and some submucosal dis-
section. One (0.7%) case ended as a piecemeal resection
and one (0.7%) case was aborted due to difficulties estab-
lishing a submucosal plane. Median lesion size was 28
(10–120) mm and median resection time was 65 (10–360)
min. Intraprocedural complications were seen in 14 (9.0%)
cases. Three were transmural small perforations and 11
cases of injury to the muscular layer without transmural
perforations. All these injuries were treated with endo-
scopic clips. There were no bleeding complications that
could not be managed with endoscopic techniques. All
patients had a clinical examination after 2–4 h and were
discharged with no significant clinical findings. They were
informed to contact the endoscopy unit or emergency
department in case of abdominal pain, fever or rectal
bleeding. All three patients with a transmural perforation
were put on peroral antibiotics for 10 days. Another 3
patients with an incision in the muscular layer were put on
peroral antibiotics at the endoscopists discretion.
The histological results of the lesions are presented in
Table 3. Of the 7 people with adenocarcinoma, 3 had
invasion \1000 micrometers into the submucosa and no
lymphovascular invasion and the resections were consid-
ered curative. Three had subsequent surgical resection, one
because of invasion[1000 micrometers and 2 with inva-
sion\1000 micrometers but lymphovascular invasion. The
remaining patient had a synchronous colon cancer with
liver metastasis and was treated with palliative intent.
Fig. 1 Consort flow diagram
Table 1 Location of included lesions
Location Numbers Percent (%)
Cekum 30 19.2
Ascending 29 18.6








R0 resection was seen in 129 (82.7%) of the cases. Rx
was seen in 25 (16.0%). One case was done with a
piecemeal resection, and one case was aborted during the
procedure. Both these cases are assigned R1. Fifteen of the
cases with Rx have had a repeat colonoscopy with no
endoscopic sign of recurrence. Seven patients are sched-
uled for a colonoscopy within the coming 6 months. Three
patients with Rx not be followed further, due to high age.
The high rate of Rx with a normal follow-up endoscopy
stresses the importance of having an adequate margin to
make pathological assessment accurate.
All patients’ medical records were reviewed 30 days
after the procedure. In the Stockholm area, some 80–90%
of the family doctors and 6 out of 7 hospitals share the
same computerized medical records and these records were
reviewed to ensure that we did not exclude medical
attention sought at another hospital/primary health care
center. A total of 8 patients had been in contact with the
Danderyd Hospital within the 30-days period, see Table 4.
Three were admitted for observation, two with abdominal
pain where a CT scan showed a local thickening of the
bowel wall and small infiltration of extraluminal gas
suggestive of microperforation or coagulation syndrome.
They were treated conservatively with antibiotics. One
patient required a blood transfusion. The other five patients
were discharged from the emergency department after a
normal clinical workup (blood tests and CT scan in case of
abdominal pain). No patient required surgery related to the
ESD-treatment during the follow-up. Of note is also that
none of the patients who had a perforation or injury to the
muscular layer during their ESD seen or readmitted to
hospital during the first 30 days.
Discussion
ESD is a technically challenging procedure with a long
learning curve. There are currently no studies that have
demonstrated that ESD can be performed as day surgery.
Length of stay after various surgical procedures has
become shorter during the past decades. In Sweden, 31% of
the laparoscopic cholecystectomies and 78% of the ingu-
inal hernia repairs were done as day surgery in 2014 [16].
The introduction of Enhanced Recovery After Surgery
(ERAS) concept in colorectal surgery has shortened length
of stay after colorectal resection stressing the importance of
early oral food intake (on the same day of surgery) and
early mobilization. The median length of stay after a
colonic resection in a unit that adhere to the ERAS concept
is now 2–3 days [17–19]. These data made us question the
strategy to keep, often elderly, patients that undergo ESD
fasting and in hospital for several days. In Japan, patients
undergoing ESD are hospitalized for 5–6 days. In a Japa-
nese study of 382 patients, the mean hospital stay after
ESD was 5.3 days. With a clinical pathway focusing on
early discharge including oral food intake on day 2 in
uncomplicated cases, the mean hospital stay was decreased
to 3.4 days [11]. Also, in a European setting, ESD patients
are treated with an initial nill per mouth and hospitalization
for 2–3 days [14]. In our study, we scheduled 171 out of
182 patients (94.0%) as day surgery, with a postESD
observation for 2–4 h in the endoscopy unit. Of the 171
patients scheduled as day surgery cases 156 were done as
day surgery cases (91.2%).
Table 2 Endoscopic characteristics of included lesions




0-IIa ? IIc 1 0.6
0-IIa ? Is 9 5.8
Submucosal tumor 1 0.6
156 100
NICE classification
Type 1 32 20.5
Type 2 121 77.6
Type 3 0 0
Unclear 3 1.9
156 100
Table 3 Histopatholgy of
included lesions
Histopathology Numbers Percent (%)
Tubular adenoma low & high grade dysplasia 48 30.8
Tubulovillous adenoma low & high grade dysplasia 63 40.4
Serrated adenoma 36 23.1
Neuroendocrine tumor 1 0.6





The two most common complications after ESD are
bleeding and perforation, both can happen either acutely or
delayed. In our series, we had a perforation rate of 1.9%
(transmural injuries) which increased to 9.0% when inju-
ries to the muscular layer were included. All injuries were
treated endoscopically and none of the patients had any
complications of the treatment. It is difficult to compare
perforation rates between studies as different definitions of
perforation are used (transmural injuries of injuries to the
muscularis propria). In one of the largest ESD cohorts
published, comprising 1111 colorectal ESD procedures,
intraprocedural perforations were seen in 4.9% and delayed
perforations in 0.4% [20]. Most intraprocedural perfora-
tions, however, are small and, if recognized, can be treated
endoscopically with clips.
In our material 4 out of 156 cases developed a delayed
bleed (2.6%). Intraprocedural bleeding problems were
managed with available endoscopic hemostatic devices in
all patients. One of 4 patients in our series with delayed
bleed required blood transfusion. Delayed bleeding has
been reported in 4.3% after colorectal ESD up to 7 days
after the procedure [21].
Eight out of the 156 cases done as day surgery seeked
medical attention within 30 days of the ESD procedure
(5.1%). Five of these 8 patients were discharged on the
same day after a medical examination including a combi-
nation of computed tomography, blood tests and clinical
examination. Three patients (1.9%) needed inpatient care.
Four of the 8 patients seeked medical attention postoper-
ative day 1, and the other 4 seeked medical attention
postoperative day 3–8. Of the 8 patients who sought
medical attention within 30 days, 5 had abdominal pain
which could possibly be a sign of an electrocoagulation
syndrome. It is thought to be caused by an electrocoagu-
lation injury to the bowel wall. This may lead to a trans-
mural burn causing abdominal pain and fever within a few
days after the injury. Electrocoagulation syndrome is
thought to occur in about 1% of all EMR. A recent review
states that Electrocoagulation syndrome is more common
after ESD than EMR, occurring in up to 9% of colorectal
ESD cases [22]. The electrocoagulation injury to the bowel
wall has a benign course in most cases. All five cases in our
series with delayed abdominal pain had a benign course.
The present study is a prospective ESD series from a
single institution. Weaknesses of the study are that it is a
single center study, patients included were more likely to
have a lesion that was easy to treat with ESD and that
patients where the procedure was technically challenging
or time-consuming were more likely to be admitted to
hospital and thus excluded from the cohort. However, even
if including those patients, serious complications were rare
with one patient requiring laparoscopic surgery for perfo-
ration and one patient requiring an emergency TEM for
bleeding control. The other admitted patients were treated
conservatively with antibiotics and were discharged the
next day. Our data suggest that a large proportion of the
patients having a colorectal ESD can safely be discharged
the same day.
When defining an uncomplicated ESD several factors
probably needs to be considered. Factors such as submu-
cosal fibrosis, intraprocedural bleeding and access to the
lesion might be of importance. All these factors could
influence the risk of injury to the muscularis propria. Pro-
cedure time is a proxy variable that might be suitable.
Median procedure time for day surgery cases in the present
study was 65 min whereas median time for patients
admitted to hospital after their procedure was 170 min.
Further studies are needed in this field.
In the present study, we aimed to evaluate the efficacy
and safety of colorectal ESD procedures in a day surgery
setting in a tertiary referral center in Sweden. This is one of
few European colorectal ESD series that include a large
proportion of lesions in cecum and ascending colon (38%).
We have demonstrated that it is feasible and safe to per-
form uncomplicated colorectal ESD in a day surgery set-
ting, when patients receive verbal and written information
Table 4 Description of patients with postESD clinical event requiring medical attention
Patient ESD location Clinical event POD# In hospital care Treatment
1 Cecum Hematochezia ? abdominal pain 1 Yes 4 days Blood transfusion, antibiotics
2 Cecum Abdominal pain 6 No –
3 Ascending Abdominal pain 1 Yes 3 days Antibiotics
4 Ascending Abdominal pain 3 No –
5 Sigmoid Abdominal pain 7 No –
6 Rectum Hematochezia 1 No –
7 Rectum Hematochezia 8 Yes 2 days Observation
8 Rectum Hematochezia 1 No –
Surg Endosc
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about the postoperative predicted course. This information
should also include information about symptoms of pos-
sible complications (bleeding, delayed perforation and
electrocoagulation injury).
In this series, an experienced Japanese endoscopist
(T.O) was full time backing up the all ESD procedure to
maintain quality control and keep the complication rates to
the standards of eastern countries.
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